HomeCancer

Cancer

Expanded Entry Program Opens within the U.S. for TLX101-CDx, Telix’s Investigational Glioma (Mind Most cancers) Imaging Agent

MELBOURNE, Australia, July 29, 2024 (GLOBE NEWSWIRE) -- Telix Prescribed drugs Restricted (ASX: TLX, Telix, the Firm) as we speak publicizes the opening...

UMass Chan scientist seeks to beat resistance to radiation remedy for breast most cancers sufferers

Arthur Mercurio, PhD Analysis geared toward figuring out the mechanisms that promote...

iCAD and Windsong Radiology Announce Strategic Industrial

NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a world chief...

DYNAMIC Scientific Trial: ctDNA Guiding Adjuvant Remedy in Stage II Colorectal Most cancers – Most cancers Community

DYNAMIC Scientific Trial: ctDNA Guiding Adjuvant Remedy in Stage II Colorectal Most cancers  Most cancers Community

Superior Lung Most cancers Deaths Dropped Considerably Since Immunotherapy Turned Commonplace-of-care | McLaren Well being Care Information

The most important population-based research up to now helps the survival advantages of immunotherapy for individuals with metastatic non-small cell lung most cancers July...

Hot Topics